Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
Open Access
- 4 May 2021
- journal article
- review article
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 13 (2), 248-256
- https://doi.org/10.1159/000515246
Abstract
Dupilumab is currently the only biologic treatment approved for moderate-to-severe atopic dermatitis. Though limited, available clinical data describing dupilumab use in pregnancy have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Systemic treatment in pregnant women with atopic dermatitis is currently restricted to corticosteroids, cyclosporine A, and azathioprine. Atopic dermatitis often has a deleterious course in pregnancy which can cause substantial distress and significantly impact on global health and quality of life. We report a case of severe atopic dermatitis treated safely with dupilumab during pregnancy with no adverse maternal or fetal outcomes observed. Our case highlights that dupilumab use in pregnancy has its place but should always be preceded by careful assessment of the risks and benefits. Clinicians are encouraged to enroll their patients in relevant pregnancy registry studies to monitor outcomes in women exposed to dupilumab during pregnancy and lactation.Keywords
This publication has 25 references indexed in Scilit:
- Treatment of rheumatoid arthritis during pregnancy: present and futureExpert Review of Clinical Immunology, 2016
- The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in PregnancyGastroenterology, 2016
- Pregnancy outcome after TNF‐α inhibitor therapy during the first trimester: a prospective multicentre cohort studyBritish Journal of Clinical Pharmacology, 2015
- Lactation and the Use of Biologic Immunosuppressive MedicationsBreastfeeding Medicine, 2014
- Treatment of atopic dermatitis in pregnancyDermatologic Therapy, 2013
- Emerging data on the use of anti‐tumor necrosis factor‐alpha medications in pregnancyBirth Defects Research Part A: Clinical and Molecular Teratology, 2012
- Atopic Dermatitis in Pregnancy: Current Status and ChallengesObstetrical & Gynecological Survey, 2011
- Allergische Erkrankungen bei SchwangerenDie Dermatologie, 2010
- Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's DiseaseJournal of Crohn's and Colitis, 2010
- Eczema herpeticatum in graviditateDeutsche Medizinische Wochenschrift (1946), 1995